Clinical Trial Update: Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of K-134 for intermittent claudication has completed. The study evaluated safety and efficacy of the treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication

Drugs mentioned

• K-134

Snippet

Sponsor: Kowa Research Institute, Inc. | Conditions: Intermittent Claudication | Phase 2 | Status: COMPLETED